JENNER VACCINE FOUNDATION
C/O JENNER INSTITUTE OLD ROAD CAMPUS RESEARCH BUILDING, ROOSEVELT DRIVE, OXFORD  OX3 7DQ- Active
- PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
- Company No. 03079818
- Last Updated: 01 Mar 2024
Company Profile
JENNER VACCINE FOUNDATION was incorporated on Friday, July 14, 1995 as a PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) with registered address in OXFORD. JENNER VACCINE FOUNDATION has the status: Active and it's listed in the following category: Research and experimental development on social sciences and humanities. This PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) has been operating for 29 years 3 months and 25 days.
Name | JENNER VACCINE FOUNDATION |
---|---|
Company number | 03079818 |
Company type | PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) |
Incorporation date | 14 Jul 1995 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
C/O JENNER INSTITUTE OLD ROAD CAMPUS RESEARCH BUILDING ROOSEVELT DRIVE OXFORD OX3 7DQ |
---|---|
Country Of Origin | ENGLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
The Pirbright Institute Ash Road, Pirbright, GU24 0NF |
Dates: Thursday, June 30, 2016 - present
voting rights 25 to 50 percent
|
Accounts and Confirmation
Type of accounts | FULL |
---|---|
End of financial Year | 31 March |
Next annual accounts due | 31 December 2024, (52 days left) |
Latest accounts | 31 March 2023 |
Next confirmation statement due | 28 July 2016 |
Last confirmation statement dated | 30 June 2015 |
Mortgages
No mortgages have been registered against JENNER VACCINE FOUNDATION.
Previous Names
Name | Change Date |
---|---|
JENNER VACCINE FOUNDATION | 14 Jul 1995 |
THE EDWARD JENNER INSTITUTE FOR VACCINE RESEARCH | 12 Oct 2006 |